The tech-heavy index was down 1.3% on Tuesday, though it rallied off its lows from earlier in the session. The Dow cut its decline to 181 points, or 0.4%. The S&P 500 was down 0.8%.
The Manila Times on MSN
Kimberly-Clark to buy Tylenol maker Kenvue in $48.7-B deal
KIMBERLY-CLARK is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54 ...
Kimberly-Clark is acquiring Tylenol maker Kenvue in a $48.7 billion cash-and-stock deal, creating a major consumer health goods company if shareholders approve.
A number of prominent hedge funds are likely applauding Monday’s news that Kimberly-Clark Corp. has agreed to acquire Kenvue ...
Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark’s stock ...
Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears ...
Kimberly-Clark plans to acquire Kenvue in a $48.7 billion deal, aiming to boost long-term growth and synergies. Learn more ...
Asian shares are trading mixed after overseas markets got a big lift from optimism over AI technology. Shares rose in Hong Kong on Tuesday, while slipping in Tokyo, Sydney and Seoul. On Wall ...
Despite a headline beat and decent revenue forecast, the poor reaction to the update from AI and data analytics darling ...
In this piece, we will look at the stocks Jim Cramer discussed.
Under the agreement, each Kenvue Inc. (NYSE:KVUE) shareholder would receive $3.5 per share in cash as well as 0.14625 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback